AxoGen, Inc.
AXGNNASDAQHealthcare● Active
$41.46
$-1.34(-3.13%)
Market Cap$2.2B
P/E Ratio—
52W High$45.83
52W Low$9.22
AxoGen, Inc. (AXGN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AXGN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.23B | $0.19B | $0.16B | $0.14B | $0.13B |
| Cost of Revenue | $0.06B | $0.05B | $0.04B | $0.03B | $0.02B |
| Gross Profit | $0.17B | $0.14B | $0.12B | $0.11B | $0.10B |
| Gross Margin %(computed) | 74.31% | 75.79% | 76.64% | 78.51% | 81.99% |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.03B | $0.03B | $0.03B | $0.02B |
| G&A Expenses | $0.04B | $0.04B | $0.04B | $0.04B | $0.03B |
| Total Operating Expenses | $0.18B | $0.15B | $0.14B | $0.14B | $0.13B |
| Operating Income | ($0.01B) | ($0.00B) | ($0.02B) | ($0.03B) | ($0.03B) |
| Operating Margin %(computed) | -3.49% | -1.75% | -13.50% | -21.44% | -19.96% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.01B) | ($0.02B) | ($0.03B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | ($0.01B) | ($0.02B) | ($0.03B) | ($0.03B) |
| Net Margin %(computed) | -6.97% | -5.32% | -13.66% | -20.89% | -21.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.34 | $-0.23 | $-0.51 | $-0.69 | $-0.65 |
| Wtd Avg Shares | 0.05B | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | $0.00B | $0.01B | ($0.01B) | ($0.02B) | ($0.02B) |
| EBITDA Margin %(computed) | 0.09% | 3.24% | -8.38% | -16.94% | -16.40% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more AxoGen, Inc. data
About AxoGen, Inc. (AXGN) Income Statement
AxoGen, Inc. (AXGN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AXGN reported revenue of $0.23B, gross profit of $0.17B (gross margin 74.31%), and net income of ($0.02B) — a net profit margin of -6.97%.
Frequently asked questions
AXGN · 4 questionsAxoGen, Inc. (AXGN) reported revenue of $0.23B for 2025, up 20.2% year-over-year.
AXGN revenueAXGN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08